- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Saga Metals
Element79 Gold Corp
Black Swan Graphene
Forum Energy Metals
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
ALROSA (MCX:ALRS) announced a loss of $283.8 million in 2014, attributed to foreign-exchange losses on the company’s U.S. dollar-denominated debt, following depreciation of the ruble in 2014.
ALROSA (MCX:ALRS) announced a loss of $283.8 million in 2014, attributed to foreign-exchange losses on the company’s U.S. dollar-denominated debt, following depreciation of the ruble in 2014.
As quoted in the press release,
ALROSA recorded a net loss of RUB 16.8 bn for the year due to increased FX loss as the result of revaluation of the US-denominated part of the debt portfolio following the ruble depreciation in 2014.
Click here for the full ALROSA (MCX:ALRS) press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.